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Context
A large collaboration was initiated in Grenoble (France) on Accelerator-Based Neutron 
Capture Therapy (AB-NCT). 
One objective is to realize a demonstrator for neutron beam production with an accelerator 
dedicated to clinical Boron Neutron Capture Therapy (BNCT), LPSC working on the design of 
an original rotating target with associated beam shaping assembly and on neutron 
directional detection (See oral presentation of Daniel Santos). 
Another aspect is to use modeling and experimental approaches to: 
- study the local dose-effect due to the direct neutron collisions and to the high-LET 
fragments following neutron capture, 
- characterize the cellular damages induced by AB-NCT (apoptosis, metabolism, cell depth)
- study the ability of AB-NCT to trigger an immunogenic cell death of tumor cells in vitro
Dedicated experiments will be performed on various cell lines (melanoma, glioblastoma, 
lung and breast cancer), under very intense and clean slow neutron beams at the research 
reactor ILL, in collaboration with the team of I. Porras (Granada University). 
AB-NCT collaboration in France
Geant4 Physics Library: QGSP_BERT_HP_LIV 
adapted to neutron transport below 20 MeV and low energy electromagnetic processes
Data collection and particle sorting (ROOT analysis): 
• Creation of a “Tracker” record all particle information at each step in tumor, brain and skull volumes. 
• Dose contributions sorted per particle type, with e- and e+ contributions attributed to their parent particle.
• Main reactions of interest: 10B(n,γ)7Li capture, 1H(n,n’)1H collisions, 14N(n,p)14C and 1H (n,)2H captures 
Geant 4 simulation
Preliminary results: Geant4 simulation with a brain tumor model
• Preliminary Monte Carlo study: we have performed a Geant4 simulation and developed an algorithm to get the BNCT 
contributors. Mixed fields for various tumor depths were calculated in a brain tumor model.
• First Cell-survival calculations with NanOxTM: very promising results. Need for experimental radiobiological data to 
constrain the model (to be done at ILL laboratory). Improvements to come: take into account the recoiling nuclei from 
neutron collisions (mainly the fast neutron component) and creation of a voxelized cartography of “biological dose”
• Need for information about boron intracellular distribution (depending on the vector) to integrate the compound effect 
in the model. 
Conclusion and Perspectives 
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We present here a very preliminary work on BNCT Dosimetry. The approach is as follows:
A full Monte Carlo calculation is used to separate all dose components and determine the 
corresponding physical dose fractions with a realistic clinical model.
These dose fractions are then used as mixed fields to predict cell-survivals and RBE values for 
a specific cell-line, thanks to the radiobiological model NanOxTM.
Objectives of this modeling study
NanOxTM: Nanodosimetry and Oxidative stress
It was originally developed to predict RBE in the context of particle 
therapy, takes into account the fully stochastic nature of ionizing 
radiation by considering dose fluctuations both at nanometric and 
micrometric scales, and integrates the oxidative stress.
NanOxTM modeling of V79 cell line irradiated with photons, protons 
and carbon ions gave promising results in terms of the description of 
overkill effect and evolution of the shoulder in cell survival curves 
with ion LET.
By estimating cell survival to mixed fields according to the Kanai 
approximation [3], NanOxTM can be used as well for a precise 
determination of RBE for BNCT (taking the physical dose fractions of 
all the field components as input). 
Our perspective: creation of a voxelized cartography of biological 
dose, integrating physical dose dependence.
[3] Kanai et al. 1997, Kanai et al. 1999
NanOxTM model
Dose Convention: dosimetry in BNCT is very complex due to many different dose components. 
Deposited doses due to these components are weighted with appropriate factors, ω, to 
determine the “weighted dose” as :
• DB: Boron dose,
10B(n,γ)7Li capture,
• DFast: Fast neutron dose, mainly proton recoil from 
1H(n,n’)1H, 
• Dther: Thermal neutron dose, mainly protons and 
14C recoils from 14N(n,p)14C captures 
• Dγ: Gamma dose, nuclear deexitation and source contamination (main peaks from 10B(n,γ)7Li 
and 1H (n,)2H captures)
The weighting factors represent relative or
compound biological effectiveness factors 
(RBE or CBE). The commonly used factors 
were determined experimentally by Coderre
et al. on glioma cell lines (for BPA compound): 
Limitations: These factors are used as constant values although they can depend on many 
variables as delivered dose, neutron energy, target cell population and boron distribution within 
tumor or normal tissue cells.
Improvements in BNCT dose calculation and RBE determination are needed 
BNCT Dosimetry: convention and limitations
Cell-survival prediction for the calculated mixed fields at 2 cm 
applied to V79 cell line 
Current limitations of the model for BNCT: recoil nuclei from neutron 
collisions not taken into account; Need for experimental radiobiological 
data to integrate the compound effect (CBE).
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Geometry: Snyder head phantom (MIRD): 
Tissue composition ICRU 46
Neutron beam approximation: 
parallel with 8 cm diameter source
monochromatic 10 keV
Dose fraction study as a function of 
the tumor depth:
-- BNCT mixed field of 
gammas, high LET protons 
(from 14N(n,p)14C capture), α
particles and 7Li ions 
modeled by NanOxTM
* Photons irradiation [4]
[4] Cox et al. 1977  
Weighted dose profiles using conventional weighting factors for a tumor depth of 6 cm
Calculated physical dose fraction to the tumor for 
the main components (tumor depth : 2 - 10 cm)
Preliminary results: NanOxTM
Calculated total 2D maps (X,Y) of deposited energy 
per cm3, with total, alpha and proton contribution. 
Superficial (2 cm) versus deep (6 cm) tumor
Mixed field used for the 
NanOxTM calculation
